Recalls Rejuvamin PM Capsules
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
June 9, 1999
Brentwood, TN (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Biocentrics is recalling Rejuvamin PM Capsules
because the product is an unapproved new drug.
This is the first public notice
issued by the FDA.
Rejuvamin PM Capsules (Gammadeoxytetronic Acid), OTC in packets of 4 units.
All lot numbers
Tishcon Corporation, Westbury, New York (contract Manufacturer).
Biocentrics, A Division of Unique Products Company, Brentwood, Tennessee, by letter
dated April 20, 1999. Firm-initiated recall ongoing.
Approximately 150 cases (each case containing 24 boxes with 30 packets inside the
box) were manufactured. All of the product was distributed except 5 boxes (150 packets).